Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2019 Apr 8;7(7):2359–2368.e3. doi: 10.1016/j.jaip.2019.03.049

Table 1:

Literature Review of Almond Challenge Outcomes

Study Design Almond Diagnostics Almond Challenge Outcomes
Andorf et al JACI in Practice 2017(10)
• n=165 patients with possible allergy to 2+foods receiving 311 challenges
• median SPT 9.5 mm (range 6–25 mm)
• median IgE 5.2 kU/L (range 0.4–100 kU/L)
• n=21 challenges to almond
• 10 reactions = 52% passage rate
• 48% with skin reaction, 0% with GI reaction, 10% with respiratory symptoms, 0% with epi
Couch et al Ann Allergy Asthma Immunol 2017(9)
• n=109 patients with tree nut allergy receiving 156 challenges
• mean sIgE 1.18 (median 0)
• mean SPT 1.27 (median 0)
• 42 with sIgE <2
• 6 with sIgE >=2
• 37 with SPT <3
• 11 with SPT >3
• 57 challenges
• 100% passage rate
Elizur et al Allergy 2018(8)
• n=83 patients with peanut / tree nut allergy receiving 232 challenges
• 49 with SPT >3 mm
• exact SPT & IgE not specified
• 49 challenges
• 1 clinical reaction = 98% passage rate
Rodriguez et al JACI 2000(9)
• n=34 with suspected Rosaceae food allergy
• performed SPT, IgE and if positive, then OFC to all Rosaceae foods (apricot, almond, plum, strawberry, apple, peach, pear)
• 4 with reported almond clinical history
• 18 with positive almond-specific SPT or IgE
• exact SPT & IgE not specified
• 18 challenges to individuals with sensitization
• 1 clinical reaction = 94% passage rate
• Only oral symptoms
• Rate of clinical reactivity for those with positive SPT (n=15): 7%
• Rate of clinical reactivity for those with positive IgE (n=6): 17%